martes, 8 de mayo de 2018

National Stroke Awareness Month (see related guidelines) 1 (1/1) | National Guideline Clearinghouse

Search | National Guideline Clearinghouse

ngc

Health Awareness Topics: May 2018

  • GUIDELINE SUMMARY
  •  
  • NGC:010417
  •  
  • 2009 MAR (REVISED 2014 MAY)

Secondary prevention of ischemic heart disease and stroke in adults.

  • GUIDELINE SUMMARY
  •  
  • NGC:010784
  •  
  • 2008 (REVISED 2015)

Occupational therapy practice guidelines for adults with stroke.

  • GUIDELINE SUMMARY
  •  
  • NGC:011011
  •  
  • 2016 JAN

Healthy lifestyles.

  • GUIDELINE SUMMARY
  •  
  • NGC:010789
  •  
  • 2013 FEB (REVISED 2015 SEP)

Clinical policy: use of intravenous tissue plasminogen activator for the management of acute ischemic stroke in the emergency department.

  • GUIDELINE SUMMARY
  •  
  • NGC:010531
  •  
  • 2014

Managing acute complications of sickle cell disease. In: Evidence-based management of sickle cell disease.

  • GUIDELINE SUMMARY
  •  
  • NGC:009625
  •  
  • 1998 AUG (REVISED 2013 JAN)

Diagnosis and treatment of headache.

  • GUIDELINE SUMMARY
  •  
  • NGC:009629
  •  
  • 2013 FEB

Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation.

Pharmacologic management of newly detected atrial fibrillation.

  • GUIDELINE SUMMARY
  •  
  • NGC:009955
  •  
  • 2013 JUN

Stroke rehabilitation. Long-term rehabilitation after stroke.

  • GUIDELINE SUMMARY
  •  
  • NGC:010399
  •  
  • 2000 MAY (REVISED 2014 MAY)

Screening and management of lipids.

  • GUIDELINE SUMMARY
  •  
  • NGC:009802
  •  
  • 2012 JUN (REVISED 2013 MAR)

Recommendations for antithrombotic agents for the prevention of stroke and systemic embolism in patients with atrial fibrillation.

  • GUIDELINE SUMMARY
  •  
  • NGC:010530
  •  
  • 2014

Health maintenance for people with sickle cell disease. In: Evidence-based management of sickle cell disease.

  • GUIDELINE SUMMARY
  •  
  • NGC:011059
  •  
  • 2016

ACR Appropriateness Criteria® cerebrovascular disease.

No hay comentarios: